XML 45 R33.htm IDEA: XBRL DOCUMENT
v3.25.1

Concentrations and Credit Risk | 3 Months Ended
--- | ---
Mar. 31, 2025
Concentrations and Credit Risk [Abstract] |
Concentrations and Credit Risk |
27. | Concentrations and Credit Risk
(a) | Concentrations
The Company had the following customers that individually comprised 10% or more of net revenue for the three months ended March 31, 2024 and 2025 as follows:
|  | Three months ended March 31, |
Sales of finished goods and raw materials |  | 2024 |  |  | 2025 |
Customer A |  | $ | 30,141,709 |  |  |  | 51.2 | % |  | $ | * |  |  |  | * |
Customer B |  |  | * |  |  |  | * |  |  |  | 10,731,179 |  |  |  | 30.7 | %
* | Comprised less than 10% of net revenue for the respective period.
The Company had the following customers that individually comprised 10% or more of net trade receivable (included VAT) as of December 31, 2024 and March 31, 2025 as follows:
|  | December 31, 2024 |  |  | March 31, 2025 |
Customer B |  | $ | 10,676,044 |  |  |  | 41.5 | % |  | $ | 9,814,866 |  |  |  | 37.5 | %
Customer C |  |  | * |  |  |  | * |  |  |  | 3,799,674 |  |  |  | 14.5 | %
Zhengzhou BAK Battery Co., Ltd (note 17) |  |  | 5,970,184 |  |  |  | 23.2 | % |  |  | * |  |  |  | * |
* | Comprised less than 10% of net accounts receivable for the respective period.
The Company had the following suppliers that individually comprised 10% or more of net purchase for the three months ended March 31, 2024 and 2025 as follows:
|  | Three months ended March 31, |
|  | 2024 |  |  | 2025 |
Supplier A |  | $ | 3,242,455 |  |  |  | 10.1 | % |  | $ | * |  |  |  | * |
Supplier B |  |  | * |  |  |  | * |  |  |  | 3,619,451 |  |  |  | 11.2 | %
* | Comprised less than 10% of net purchase for the respective period.
The Company had the following suppliers that individually comprised 10% or more of trade payable as of December 31, 2024 and March 31, 2025 as follows:
|  | December 31, 2024 |  |  | March 31, 2025 |
Supplier B |  | $ | 3,263,562 |  |  |  | 12.4 | % |  | $ | * |  |  |  | * |
(b) | Credit Risk
Financial instruments that potentially subject the Company to a significant concentration of credit risk consist primarily of cash and cash equivalents and pledged deposits. As of December 31, 2024 and March 31, 2025 substantially all of the Company’s cash and cash equivalents were held by major financial institutions and online payment platforms located in the PRC, which management believes are of high credit quality. The Company has not experienced any losses on cash and cash equivalents to date. The Company does not require collateral or other securities to support financial instruments that are subject to credit risk. For the credit risk related to trade accounts receivable, the Company performs ongoing credit evaluations of its customers and, if necessary, maintains reserves for potential credit losses.

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (d)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (d)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 3A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482836/275-10-55-3A Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-2A Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1 Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/275/tableOfContent + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration